Download Capability Statement
Federal Prime Contractor

Translating Science into Medical Solutions

SeligAB delivers compliant biotechnology research, advanced biomaterials, and regulatory-compliant synthesis to United States defense and health agencies.

CAGE

Active Registration

UEI

SAM.gov Verified

Request Technical Brief
Core Capabilities

Institutional Research Infrastructure

We bridge raw scientific discovery with strict regulatory validation, engineering clinical-track biomaterials and drug delivery systems that satisfy rigorous federal compliance standards.

Biomaterials Synthesis

Targeted Drug Delivery

Regulatory Engineering

Synthesis of biocompatible materials engineered for extreme field environments and clinical translation.

Advanced micro-encapsulation and nanoparticle systems designed for controlled, high-efficacy therapeutic release.

Complete IND-track documentation, technical writing, and compliance mapping for federal health agencies.

Procurement Data

Federal Registration Identifiers

Primary NAICS Classifications

Active Corporate Registrations

We operate under primary NAICS codes 541715 (Biotechnology R&D) and 541714 (Life Sciences), alongside 325412 and 325414 for pharmaceutical and biological preparation manufacturing.

Fully registered in SAM.gov. CAGE Code and Unique Entity ID (UEI) are active and available for prime or subcontracting partnerships across all federal health agencies.

Macro close-up of a precise synthetic biomaterial structure under cool laboratory light, showcasing intricate micro-channels with subtle gold highlights, shallow depth of field.
Macro close-up of a precise synthetic biomaterial structure under cool laboratory light, showcasing intricate micro-channels with subtle gold highlights, shallow depth of field.
Proven Execution

Translational Milestones

Military Medicine Synthesis

Under collaborative frameworks, SeligAB has engineered stable, field-deployable biomaterials designed for rapid wound stabilization. Our protocols ensure reproducibility under extreme operational constraints.

Academic Translation

Partnering with tier-one research universities, we successfully transitioned high-risk molecular models into validated, regulatory-compliant drug delivery prototypes ready for preclinical evaluation.

Secure Inquiries

Initiate Procurement Discussions

Connect directly with our contracting officers in Texas to discuss prime opportunities, subcontracts, or joint research proposals.